Kaneka Probiotics launches L. plantarum DR7 for immune support

By Stephen Daniells contact

- Last updated on GMT

© image_jungle / Getty Images
© image_jungle / Getty Images

Related tags: Probiotics, Respiratory tract infections, immune support

Texas-based Kaneka Probiotics has launched Lactobacillus plantarum DR7 for immune support supplements, with the strain’s efficacy supported by clinical trials.

The DR7 strain was isolated originally from fresh bovine milk, and its potential benefits respiratory health were reported in a randomized-controlled clinical trial published in the Journal of Dairy Science*​.

The study included 109 adults randomly assigned to receive either one billion CFUs of DR7 per day or placebo for 12 weeks. The data indicated that the probiotic was associated with decreased levels of pro-inflammatory cytokines such as TNF-alpha and IFN-gamma in the subjects, as well as reduced the duration of nasal symptoms.

Another paper in the journal Beneficial Microbes**​ reported that the same dose of DR7 was associated with improved cognitive and memory functions in normal adults compared to placebo, and these improvements were noted for basic attention, emotional cognition, and associate learning.

The strain also enhanced the serotonin pathway. By upregulating the tryptophan-serotonin pathway, there is a de-emphasis of the tryptophan-kyneurine pathway, which is associated with a weaker immunity, explained the company in a press release.

“A particularly unique aspect of this strain is its ability to enhance immune function in normal ranges, promote the protection of the Upper Respiratory Tract, and help the body modulate of the Gut Brain Axis,”​ said Mike Kolifrath, Vice President of the Kaneka Probiotics Division.

“Our DR7 is a Kaneka Probiotics exclusive and presents a new option for product developers in creating specialized products in the Immune, Brain and Gut-Brain Axis categories.”

* Journal of Dairy Science
2019, Volume 102, Issue 6, Pages 4783-4797, doi: 10.3168/jds.2018-16103
Lactobacillus plantarum DR7 improved upper respiratory tract infections via enhancing immune and inflammatory parameters: A randomized, double-blind, placebo-controlled study
Authors: H-X Chong, et al.

** Beneficial Microbes
2019, Volume 10, Issue 4, Pages 355-373, doi: 10.3920/BM2018.0135
Lactobacillus plantarum DR7 alleviates stress and anxiety in adults: a randomised, double-blind, placebo-controlled study”
Authors: H-X Chong, et al.

Related news

Show more

Related products

show more

LIPOFER™: a bioavailable and stable source of iron

LIPOFER™: a bioavailable and stable source of iron

Lipofoods, a Lubrizol Company | 17-Nov-2022 | Technical / White Paper

Maintaining adequate iron levels is critical to maintaining a healthy body, with deficiencies being the cause of several health issues including anemia...

Supplier of high-quality nutritional ingredients

Supplier of high-quality nutritional ingredients

Actylis – The Partner of Choice | 20-Oct-2022 | Product Brochure

By combining 75+ years of manufacturing and sourcing expertise, Actylis provides over 250 high-quality ingredients to the nutrition market, including amino...

Related suppliers

Follow us

Products

View more

Webinars